Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Promising news for older AML patients

    ... study at the 2016 annual meeting of the American Society of Clinical Oncology, induced a combined rate of complete remission (CR) and CR ... was supported by Abbvie and Genentech. Dr. Pratz disclosed research funding from Abbvie and other companies ...

    Article last updated 07/19/2017 - 11:19am.

  2. Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.

    ... In conclusion, subsets of t-MDS patients with varying clinical outcomes can be identified using conventional risk stratification ...

    Research Article last updated 03/09/2017 - 1:27pm.

  3. PACCT+ Patient Committee Holds First Meeting

    ... On September 24, the AAMDSIF Patient Advisory Council on Clinical Trials (PACCT+) members met in Arlington, Virginia for an orientation ... and the state of current bone marrow failure (BMF) research. PACCT+ is a two-year demonstration project to develop and test a ...

    Article last updated 01/23/2017 - 2:12pm.

  4. Low Dose Danazol for the Treatment of Telomere Related Diseases

    For more details on this clinical trial, including contact information, please see this trial’s ... showed a positive influence on telomere length. Additional research is needed to learn more about the role of different doses of danazol ...

    Clinical Trial last updated 05/31/2018 - 2:53pm.

  5. Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs. de novo myelodysplastic syndromes: A report on behalf of the MDS clinical research consortium

    ... In conclusion, subsets of t-MDS patients with varying clinical outcomes can be identified using conventional risk stratification ...

    Research Article last updated 02/03/2017 - 10:09am.

  6. A Remarkable Response in a Clinical Trial

    ... a normal life for the next seven months. However, much of my research told me otherwise. MDS was just smoldering, and not gone. I had ... I had only a few months to live unless I found a clinical trial and soon. Neither of the two oncologists offered to help me ...

    Patient Chronicle last updated 04/26/2018 - 12:46pm.

  7. Announcing AAMDSIF 2016 Research Awards

    ... We are pleased to be able the recipients of the 2016 research awards in bone marrow failure . This year we had dozens of ... in the blood of patients with MDS and this predicts a poor clinical outcome. We demonstrate that changes in the stroma increase ...

    Article last updated 06/09/2016 - 12:45pm.

  8. New data presented at ASCO on secondary MDS/AML

    ... The data, presented at the 2017 American Society of Clinical Oncology (ASCO 2017) annual meeting in Chicago by Nicole Fulcher, et ... greater in subcohorts exposed to DNA-damaging agents. Future research should more accurately judge the association of MDS/AML with exposure ...

    Article last updated 06/05/2017 - 9:37am.

  9. AAMDSIF and PNH Foundation To Merge

    ... Barbara Holzer, 301-279-7202, holzer@aamds.org PNH Research and Support Foundation to Merge With Aplastic Anemia and MDS ... innovative and collaborative research through the MDS Clinical Research Consortium and with its own research grant program. Based ...

    Article last updated 11/01/2016 - 10:05am.

  10. AAMDSIF Salutes Its Volunteers During National Volunteer Week!

    ... (MAB) This outstanding group of over 20 medical and research professionals are leaders in their fields. Their scientific guidance ... we can provide. Patient Advisory Council on Clinical Trials (PACCT+) This recently formed council is made of almost 20 ...

    Article last updated 04/18/2017 - 1:28pm.